|
🐜
|
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
73 auth.
L. Kiemeney,
S. Thorlacius,
P. Sulem,
F. Geller,
K. Aben,
S. Stacey,
J. Gudmundsson,
Margret Jakobsdottir,
J. Bergthórsson,
A. Sigurdsson,
T. Blondal,
J. Witjes,
S. Vermeulen,
C. H. D. Kaa,
D. Swinkels,
...
M. Ploeg,
E. Cornel,
H. Vergunst,
T. Thorgeirsson,
D. Gudbjartsson,
S. A. Gudjonsson,
G. Thorleifsson,
Kari Kristinsson,
Magali Mouy,
S. Snorradóttir,
D. Placidi,
M. Campagna,
C. Arici,
K. Koppová,
E. Gurzău,
P. Rudnai,
E. Kellen,
E. Kellen,
S. Polidoro,
S. Polidoro,
S. Guarrera,
S. Guarrera,
C. Sacerdote,
Manuel Sanchez,
B. Saez,
Gabriel Valdivia,
Charlotta Ryk,
P. J. Verdier,
A. Lindblom,
K. Golka,
D. Bishop,
M. Knowles,
S. Nikulasson,
V. Pétursdóttir,
E. Jonsson,
G. Geirsson,
Baldvin Kristjánsson,
J. Mayordomo,
G. Steineck,
S. Porru,
F. Buntinx,
F. Buntinx,
M. P. Zeegers,
M. P. Zeegers,
T. Fletcher,
Rajiv Kumar,
G. Matullo,
G. Matullo,
P. Vineis,
P. Vineis,
A. Kiltie,
J. Gulcher,
U. Thorsteinsdóttir,
U. Thorsteinsdóttir,
A. Kong,
T. Rafnar,
K. Stefánsson,
K. Stefánsson
|
8 |
2008 |
8
🐜
|
|
🐜
|
The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
11 auth.
D. Somford,
Esther H J Hamoen,
J. Fütterer,
J. Basten,
C. H. D. Kaa,
W. Vreuls,
...
I. Oort,
H. Vergunst,
L. Kiemeney,
J. Barentsz,
J. Witjes
|
7 |
2013 |
7
🐜
|
|
🐜
|
Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
10 auth.
R. S. Post,
L. Kiemeney,
Marjolein J L Ligtenberg,
J. Witjes,
C. H. D. Kaa,
D. Bodmer,
...
L. Schaap,
C. Kets,
J. V. Krieken,
N. Hoogerbrugge
|
7 |
2010 |
7
🐜
|
|
🐜
|
Amplification of chromosome subregion 12p11.2-p12.1 in a metastasis of an i(12p)-negative seminoma: relationship to tumor progression?
10 auth.
R. Suijkerbuijk,
R. Sinke,
D. Weghuis,
L. Roque,
A. Forus,
F. Stellink,
...
A. Siepman,
C. H. D. Kaa,
J. Soares,
A. G. Kessel
|
6 |
1994 |
6
🐜
|
|
🐬
|
Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model
J. Falke,
J. Parkkinen,
L. Vaahtera,
C. H. D. Kaa,
E. Oosterwijk,
J. Witjes
|
4 |
2018 |
4
🐬
|
|
🐜
|
Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study.
19 auth.
R. Vernooij,
R. Cremers,
H. Jansen,
D. Somford,
L. Kiemeney,
G. V. Andel,
B. Wijsman,
M. Busstra,
R. V. Moorselaar,
E. M. Wijnen,
...
F. Pos,
M. Hulshof,
P. Hamberg,
F. Berkmortel,
C. H. D. Kaa,
G. Leenders,
J. Fütterer,
I. Oort,
K. Aben
|
4 |
2020 |
4
🐜
|
|
🐜
|
Cigarette smoking, von Hippel–Lindau gene mutations and sporadic renal cell carcinoma
9 auth.
Boukje A. C. Dijk,
B. V. Dijk,
L. Schouten,
E. Oosterwijk,
C. H. D. Kaa,
L. Kiemeney,
...
R. Goldbohm,
J. Schalken,
P. Brandt
|
4 |
2006 |
4
🐜
|
|
🐜
|
Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study.
18 auth.
B. Rijksen,
F. Pos,
M. Hulshof,
R. Vernooij,
H. Jansen,
G. van Andel,
B. Wijsman,
D. M. Somford,
M. Busstra,
R. J. V. van Moorselaar,
...
C. H. D. Kaa,
G. V. van Leenders,
P. Hamberg,
F. van den Berkmortel,
J. Fütterer,
L. Kiemeney,
I. V. van Oort,
K. Aben
|
3 |
2019 |
3
🐜
|
|
🐜
|
298 VALUE OF 3 TESLA MULTIMO DALITY MR GUIDED BIOPSY (MRGB) TO DETECT PROSTATE CANCER IN PATIENTS AFTER AT LEAST TWO PREVIOUS NEGATIVE BIOPSIES AND AN ELEVATED PSA
9 auth.
T. Hambrock,
D. Somford,
J. Fütterer,
C. Hoeks,
C. H. D. Kaa,
I. Oort,
...
J. Basten,
J. Witjes,
J. Barentsz
|
1 |
2009 |
1
🐜
|
